![Novo Nordisk issues voluntary nationwide recall of Levemir®, Tresiba®, Fiasp®, Novolog® and Xultophy® product samples due to improper storage temperature conditions Novo Nordisk issues voluntary nationwide recall of Levemir®, Tresiba®, Fiasp®, Novolog® and Xultophy® product samples due to improper storage temperature conditions](https://mma.prnewswire.com/media/1393815/Novo_Nordisk_White_Blue_Logo.jpg?p=twitter)
Novo Nordisk issues voluntary nationwide recall of Levemir®, Tresiba®, Fiasp®, Novolog® and Xultophy® product samples due to improper storage temperature conditions
Novo Nordisk Receives FDA Approval for Xultophy® 100/3.6 (insulin degludec and liraglutide injection)
![These highlights do not include all the information needed to use XULTOPHY 100/3.6 safely and effectively. See full prescribing information for XULTOPHY 100/3.6. XULTOPHY® 100/3.6 (insulin degludec and liraglutide) injection, for subcutaneous These highlights do not include all the information needed to use XULTOPHY 100/3.6 safely and effectively. See full prescribing information for XULTOPHY 100/3.6. XULTOPHY® 100/3.6 (insulin degludec and liraglutide) injection, for subcutaneous](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-09.jpg&id=719817)
These highlights do not include all the information needed to use XULTOPHY 100/3.6 safely and effectively. See full prescribing information for XULTOPHY 100/3.6. XULTOPHY® 100/3.6 (insulin degludec and liraglutide) injection, for subcutaneous
![BUY (Insulin Degludec And Liraglutide) (Xultophy 100/3.6) 100; 3.6 [iU]/mL; mg/mL from GNH India at the best price available. BUY (Insulin Degludec And Liraglutide) (Xultophy 100/3.6) 100; 3.6 [iU]/mL; mg/mL from GNH India at the best price available.](https://www.gnhindia.com/wp-content/uploads/2020/04/setid21335fe4-d395-4501-ac2a-2f20d7520da9nameimage-06.jpg)